NOVARTIS AG 05/03/2024 AGM
1.1Approve Financial StatementsAbstain
1.2Approve Non-Financial StatementsAbstain
2Discharge from liability of the members of the Board of Directors and the Executive CommitteeFor
3Approve the DividendFor
4Capital reduction by cancellation of sharesFor
5.1Approve Maximum Aggregate Amount of Compensation for the Board of DirectorsFor
5.2Binding vote on the maximum aggregate amount of compensation for the Executive CommitteeOppose
5.3Advisory Vote on the 2023 Compensation ReportOppose
6.1Re-elect Joerg Reinhardt as Board Member and ChairOppose
6.2Re-elect Nancy C. AndrewsFor
6.3Re-elect Ton Buechner For
6.4Re-elect Patrice Bula Abstain
6.5Re-elect Elizabeth DohertyFor
6.6Re-elect Bridgette HellerFor
6.7Re-elect Daniel HochstrasserFor
6.8Re-elect Frans van Houten For
6.9Re-elect Simon Moroney For
6.10Re-elect Ana de Pro GonzaloFor
6.11Re-elect Charles L. Sawyers For
6.12Re-elect William T. Winters For
6.13Re-elect John D. Young For
7.1Re-elect Compensation Committee Member: Patrice BulaFor
7.2Re-elect Compensation Committee Member: Bridgette HellerFor
7.3Re-elect Compensation Committee Member: Simon MoroneyFor
7.4Re-elect Compensation Committee Member: William T. WintersOppose
8Re-elect KPMG as AuditorsFor
9Re-elect f lic. iur. Peter Andreas Zahn, attorney at law, Basel, as Independent ProxyFor